Sort
40,608 grants matching “prostate cancer”
Housing assistance, Outcomes, Medicare, and SEER (HOMES): using a novel data linkage to understand cancer inequities
$527,863Craig Evan Pollack · Johns Hopkins University · R01 · FY2023 · CA
Androgen Activation of Innate Immune Signaling to Enhance Prostate Cancer Immune Response
$527,817Sushant Krishna Kachhap · Johns Hopkins University · R01 · FY2022 · CA
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer
$527,769Jay H Fowke · Vanderbilt University · R01 · FY2011 · CA
Development of VN/14-1 and Related Analogs for Breast Cancer Therapy
$527,599Vincent Collins Ofuka Njar · Thomas Jefferson University · R01 · FY2011 · CA
Qualifying Multi-Transcript Signatures for Active Surveillance of Prostate Cancer
$527,589Hyung L Kim · Cedars-Sinai Medical Center · R01 · FY2016 · CA
INFRASRUCTURE SUPPORT AND DATA ENHANCEMENTS FOR THE CARET BIOREPOSITORY
$527,567Gary E Goodman · Fred Hutchinson Cancer Research Center · UM1 · FY2017 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
Changing brachytherapy with MRI remnant-tumor segmentation and active-catheter placement
$527,521Akila Viswanathan · Johns Hopkins University · R01 · FY2021 · CA
DEREGULATION OF MIRNAS CONTRIBUTES TO DEVELOPMENT AND PROGRESSION OF PROSTATE CANCER
$527,373University Of California, Davis · · FY2009 · Department of the Army
Early Detection of Cancer By Affinity Mass Spectrometry
$527,202Eastern Virginia Medical School · U01 · FY2004 · CA
Multi Source E-Beam kV X-Ray Tube for Image-Guided Radiotheraphy
$526,918Douglas P Boyd · Telesecurity Sciences, Inc. · R44 · FY2017 · CA
Intracellular Self-Assembly of Theranostic Nanoparticles for Enhanced Imaging and Tumor Therapy
$526,892Jeff W Bulte · Johns Hopkins University · R01 · FY2022 · EB
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$526,795Alan Ashworth · University Of California, San Francisco · R01 · FY2019 · CA
GLOBAL CHARACTERIZATION OF PROTEIN-ALTERING MUTATIONS IN PROSTATE CANCER
$526,772Fred Hutchinson Cancer Research Center · · FY2010 · Department of the Army
High-Specificity Imaging Agents for Aggressive Prostate Cancer
$526,681Martin G Pomper · Johns Hopkins University · R01 · FY2016 · CA
DEFINING AND EXPLOITING THE MOLECULAR AND CELLULAR RESPONSES TO SUPRAPHYSIOLOGICAL ANDROGENS FOR PROSTATE CANCER TREATMENT
$526,680Fred Hutchinson Cancer Center · · FY2025 · Defense Health Agency
Endoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and Treatment
$526,598J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2025 · CA
Endoplasmic Reticulum-to-Mitochondria Calcium Transfer in Pancreatic Cancer Development, Metastasis, and Treatment
$526,598J. Kevin Kevin Foskett · University Of Pennsylvania · R01 · FY2021 · CA
Molecular mechanisms of tumor-initiated premetastatic niche formation in lung str
$526,470Vivek Mittal · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$526,425Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA
EPIGENETIC REGULATORS OF LINEAGE PLASTICITY IN PROSTATE CANCER
$526,362Dana-Farber Cancer Institute, Inc. · · FY2022 · Defense Health Agency
Ultra-Low Count Quantitative SPECT for Alpha-Particle Therapies
$526,222Abhinav K Jha · Washington University · R01 · FY2022 · EB
Increasing Recruitment of underrepresented cancer survivors with awareness enhancing interventions (RUN AWEI)
$526,197Michelle Y Martin · University Of Tennessee Health Sci Ctr · R01 · FY2020 · CA
The development of novel radiation-sensitizer based on ultra-small carbon dots
$526,148Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA